Hepatitis C: somber views of natural history and optimistic views of interferon treatment?

Clinical Trial

T Poynard et al. Hepatology. 1998 May.

. 1998 May;27(5):1443-4.

doi: 10.1002/hep.510270537.

No abstract available

Comment on

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.
Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Kiyosawa K, Okuda M, Hino K, Okita K. Kasahara A, et al. Hepatology. 1998 May;27(5):1394-402. doi: 10.1002/hep.510270529. Hepatology. 1998. PMID: 9581697 Clinical Trial.
Determinants of outcome of compensated hepatitis C virus-related cirrhosis.
Serfaty L, Aumaître H, Chazouillères O, Bonnand AM, Rosmorduc O, Poupon RE, Poupon R. Serfaty L, et al. Hepatology. 1998 May;27(5):1435-40. doi: 10.1002/hep.510270535. Hepatology. 1998. PMID: 9581703